We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

95 hedge funds and large institutions have $141M invested in Sciclone Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 41 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $409K | Put options by funds: $163K

16% more capital invested

Capital invested by funds: $122M → $141M (+$19M)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 96 → 95 (-1)

41% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 41

Holders
95
Holders Change
-1
Holders Change %
-1.04%
% of All Funds
2.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
24
Reduced
41
Closed
14
Calls
$409K
Puts
$163K
Net Calls
+$246K
Net Calls Change
+$377K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$4.96M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.15M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$630K
4
Norges Bank
Norges Bank
Norway
+$525K
5
SAM
Shell Asset Management
Netherlands
+$481K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$1.5M
2
BFA
BlackRock Fund Advisors
California
-$1.28M
3
BA
BlackRock Advisors
Delaware
-$1.24M
4
DC
Deere & Company
Illinois
-$706K
5
QBFM
QS Batterymarch Financial Management
New York
-$435K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
26
STRS Ohio
Ohio
$705K -$34.5K -7,100 -5%
GCP
27
GSA Capital Partners
United Kingdom
$683K +$65.3K +13,417 +12%
Charles Schwab
28
Charles Schwab
California
$612K -$3.89K -800 -0.7%
Citadel Advisors
29
Citadel Advisors
Florida
$552K -$417K -85,604 -45%
AllianceBernstein
30
AllianceBernstein
Tennessee
$536K -$4.62K -949 -0.9%
SAM
31
Shell Asset Management
Netherlands
$519K +$481K +98,751 New
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$510K -$214K -43,992 -31%
RFC
33
Russell Frank Company
Washington
$505K – – –
Two Sigma Investments
34
Two Sigma Investments
New York
$502K +$161K +33,093 +53%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$494K -$19K -3,900 -4%
CS
36
Credit Suisse
Switzerland
$417K -$131K -26,841 -25%
TA
37
Teachers Advisors
New York
$404K -$5K -1,028 -1%
Goldman Sachs
38
Goldman Sachs
New York
$385K +$2.26K +464 +0.6%
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$355K -$57.1K -11,738 -15%
Morgan Stanley
40
Morgan Stanley
New York
$344K +$256K +52,634 +407%
GS
41
Gagnon Securities
New York
$336K -$74.6K -15,337 -19%
Millennium Management
42
Millennium Management
New York
$332K +$111K +22,847 +57%
Swiss National Bank
43
Swiss National Bank
Switzerland
$311K – – –
ProShare Advisors
44
ProShare Advisors
Maryland
$296K -$191K -39,162 -41%
BA
45
Boston Advisors
Massachusetts
$290K +$66.6K +13,691 +33%
Deutsche Bank
46
Deutsche Bank
Germany
$287K +$66K +13,557 +33%
GMIM
47
General Motors Investment Management
New York
$283K +$73.9K +15,196 +39%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$275K -$97 -20 -0%
KCM
49
Kennedy Capital Management
Missouri
$274K +$254K +52,183 New
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$264K +$80.4K +16,513 +49%
1
2
3 4 5

SCLN Hedge Fund Activity: Q2 2014 in Review

95 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2014, worth a combined $141M — up 16% from $122M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SCLN and 13 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 24 added.

The largest buyer was Franklin Resources, adding an estimated $4.96M. The largest seller was BlackRock Institutional Trust, cutting an estimated $1.5M.

  • 95 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2014, down from 96 in Q1 2014.
  • Funds reported $141M of Sciclone Pharmaceuticals Inc stock for Q2 2014, up 16% quarter-over-quarter.
  • 13 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2014 and 14 closed out, a net change of -1 holder.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q2 2014 was Franklin Resources, an estimated $4.96M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q2 2014 was BlackRock Institutional Trust, an estimated $1.5M sold.

Based on aggregated 13F filings for Q2 2014.